Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials

BACKGROUND: Peripheral blood parameters are correlated to immune‐checkpoint inhibitor efficacy in solid tumors, such as melanoma and non‐small cell lung cancer. Few data are currently available on the prognostic role of these immune‐inflammatory biomarkers for other solid tumors and immunotherapy co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Criscitiello, Carmen, Marra, Antonio, Morganti, Stefania, Zagami, Paola, Viale, Giulia, Esposito, Angela, Curigliano, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Immuno‐Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648370/
https://ncbi.nlm.nih.gov/pubmed/32785940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados